跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8 条关于
“Arbli”
全部
8
临床试验
0
药物
0
机构
0
资讯
8
4个月前
Scienture Secures Third Patent for ARBLI Losartan Oral Suspension, Extending Market Exclusivity Through 2041
去年
Scienture Secures FDA Orange Book Patent Listing for ARBLI™ Losartan Potassium Oral Suspension
去年
Scienture's Arbli Becomes First FDA-Approved Ready-to-Use Liquid Losartan, Securing Major Market Access
去年
FDA Approves First Liquid Losartan Formulation for Hypertension Treatment
去年
FDA Supports Novel Endpoints for ABLi Therapeutics' Risvodetinib Phase 3 Trial in Parkinson's Disease
7个月前
ABLi Therapeutics Partners with Michael J. Fox Foundation to Test Risvodetinib in Parkinson's Prevention Trial
4个月前
ABLi Therapeutics Strengthens Board with Neurodegeneration Expert Dr. Rachelle Doody Ahead of Phase 3 Trials
8个月前
SynuSight, ABLi Therapeutics, and XingImaging Partner to Advance Alpha-Synuclein PET Imaging in Parkinson's Disease Trials